The TRITON-TIMI @ ( Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction @ ) enrolled @,@ patients with an acute coronary syndrome ( ACS ) and planned percutaneous coronary intervention ( PCI ) , and randomized them to clopidogrel or prasugrel .